MOTS-c
20mg
- Ships same or next day Orders before 3PM EST, FedEx 2-Day Air
- Verify this lot View the lab reports · View the Vanguard certificate
- Real U.S. support Live chat and email, 7 days a week
For research use only. Not for human or veterinary consumption.
Certified-Pep only sells U.S.-made peptides and products.
Key Features:
Made in the USA
Batch tested at a verifiable U.S. laboratory for identity, content and purity
Screened for endotoxins, heavy metals and sterility
Rigorous quality testing on every batch
All products are delivered in lyophilized powder form
For laboratory and research use only
- PURITY: 99%+
- CAS: 1627580-64-6
- FORM: LYOPHILIZED POWDER
- DOSAGE: 20 MG
- PURITY: 99%+
| MOTS C 20MG | |
|---|---|
| SKU | CP_MOTS_C_20MG_3ML_VIAL |
| CATEGORY | Research Compound |
| CAS | 1627580-64-6 |
| VIAL SIZE | 3 mL |
| FORM | LYOPHILIZED POWDER |
| MOLECULAR WEIGHT | 2174.6 g/mol |
| SEQUENCE | Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg |
| MOLECULAR FORMULA | C101H152N28O22S2 |
| ITEM ID | 4315 |
A 2026 study characterized MOTS-c as an amphipathic, cationic peptide with direct antibacterial activity. In vitro, MOTS-c targeted Escherichia coli and methicillin-resistant Staphylococcus aureus (MRSA) membranes via its hydrophobic and cationic domains. In a murine acute peritonitis model, MOTS-c neutralized MRSA infectivity. In human monocyte cultures, interferon-γ, lipopolysaccharides, and differentiation signals each induced endogenous MOTS-c expression. Exogenous MOTS-c applied during primary mouse monocyte differentiation reprogrammed cells into macrophages with distinct transcriptomic signatures related to antigen presentation and interferon signaling, with shifted metabolic profiles and altered bacterial clearance capacity [1].
Sale